Cargando…
Structure-Based Virtual Screening and Molecular Dynamics Simulation to Identify Potential SARS-CoV-2 Spike Receptor Inhibitors from Natural Compound Database
The outbreak of respiratory disease, COVID-19 caused by SARS-CoV-2 has now been spread globally and the number of new infections is rising every moment. There are no specific medications that are currently available to combat the disease. The spike receptor of SARS-CoV-2 facilitates the viral entry...
Autores principales: | Sarkar, Arkadeep, Sen, Debanjan, Sharma, Ashutosh, Muttineni, Ravi Kumar, Debnath, Sudhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374036/ https://www.ncbi.nlm.nih.gov/pubmed/34426710 http://dx.doi.org/10.1007/s11094-021-02441-w |
Ejemplares similares
-
Three-dimensional quantitative structure-activity relationships and docking studies of some structurally diverse flavonoids and design of new aldose reductase inhibitors
por: Chandra De, Utpal, et al.
Publicado: (2015) -
Identification of potential edible mushroom as SARS-CoV-2 main protease inhibitor using rational drug designing approach
por: Sen, Debanjan, et al.
Publicado: (2022) -
Discovery of novel potential selective HDAC8 inhibitors by combine ligand-based, structure-based virtual screening and in-vitro biological evaluation
por: Debnath, Sudhan, et al.
Publicado: (2019) -
Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein
por: Power, Helen, et al.
Publicado: (2022) -
Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations
por: Zhang, Chuanming, et al.
Publicado: (2022)